Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 22:07 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableCompletedINTERVENTIONAL

Home Pregnancy Test Evaluation Study

ClinicalTrials.gov · NCT03589534 · Registry updated: 2018-11-09

Condition / research focus: Pregnancy Testing
Sponsor: SPD Development Company Limited
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2018-06-06. Completion: 2018-08-13 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

home pregnancy test (diagnostic_test)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

SPD Development Company Ltd.
Bedford, Bedfordshire, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Clearblue Home Pregnancy Test Consumer Study

ClinicalTrials.gov · NCT01279486 · Registry updated: 2018-11-02

Condition / research focus: Pregnancy
Sponsor: SPD Development Company Limited
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2010-12. Completion: 2011-06 (may be estimated). Results are posted in this registry.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 2 listed sites

Bedford General Hospital
Bedford, Bedfordshire, United Kingdom
Site recruitment: Not reported
Brook clinic
Milton Keynes, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients

ClinicalTrials.gov · NCT02273791 · Registry updated: 2018-10-29

Condition / research focus: Infertility; Polycystic Ovarian Syndrome
Sponsor: Mansoura University
Countries with listed sites: Egypt
Registry dates and results: Start: 2013-12. Completion: 2016-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Estradiol valerate (drug) — also listed as: Cycloprogynova (white tablets)
Sequential Clomiphene citrate and Gonadotropin (drug) — also listed as: Sequential Clomid and Menogon

Where the study takes place — 2 listed sites

Fertility Care Unit (FCU) in Mansoura University Hospital
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Not reported
Private fertility care centers
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS

ClinicalTrials.gov · NCT01815138 · Registry updated: 2018-10-26

Condition / research focus: Ovarian Hyperstimulation Syndrome
Sponsor: UConn Health
Countries with listed sites: United States
Registry dates and results: Start: 2013-03. Completion: 2016-10 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG (drug) — also listed as: Pregnyl, Profasi
hCG (drug) — also listed as: Pregnyl, Profasi

Where the study takes place — 1 listed sites

University of Connecticut Health Center
Farmington, Connecticut, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2TerminatedINTERVENTIONAL

Single Agent JNJ-56022473 in MDS and AML Patients FAILING HYPOMETHYLATING AGENT BASED THERAPY

ClinicalTrials.gov · NCT02992860 · Registry updated: 2018-10-25

Condition / research focus: Myelodysplastic Syndrome (MDS); Acute Myeloid Leukemia (AML)
Sponsor: GWT-TUD GmbH
Countries with listed sites: France · Germany
Registry dates and results: Start: 2016-07. Completion: 2018-10 (may be estimated). No results posted in this registry response.

Products and interventions (9)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

JNJ-56022473 (drug) — also listed as: CSL362
Bone marrow analyses and CBC with differential (procedure)
Flow cytometry analyses (other)
Central biobanking (other)
Histopathology analysis (procedure)
Cytogenetic analysis (genetic)
Serum chemistry (procedure)
Automated CBC (procedure)
Pregnancy Test (procedure)

Where the study takes place — 10 listed sites

CHU Nantes
Nantes, France
Site recruitment: Not reported
Hospital Archet 1
Nice, France
Site recruitment: Not reported
Hospital Saint Louis
Paris, France
Site recruitment: Not reported
CHU Toulouse
Toulouse, France
Site recruitment: Not reported
Klinikum Chemnitz gGmbH, Klinik für innere Medizin III
Chemnitz, Germany
Site recruitment: Not reported
Universitätsklinikum Dresden
Dresden, Germany
Site recruitment: Not reported
Heinrich Heine Universität
Düsseldorf, Germany
Site recruitment: Not reported
Marien Hospital GmbH
Düsseldorf, Germany
Site recruitment: Not reported
Technische Universität München, Klinikum rechts der Isar
Munich, Germany
Site recruitment: Not reported
Universitätsklinikum Ulm
Ulm, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Piloting Use of Multi-Level Pregnancy Tests in Remote Abortion Services

ClinicalTrials.gov · NCT03207880 · Registry updated: 2018-09-27

Condition / research focus: Medical Abortion, Complete or Unspecified, Without Complication
Sponsor: Gynuity Health Projects
Countries with listed sites: United States
Registry dates and results: Start: 2017-11-01. Completion: 2018-08-10 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Multi-level pregnancy test (device)

Where the study takes place — 1 listed sites

Gynuity Health Projects
New York, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Periodontal Treatment Response in Type II Diabetic Patients

ClinicalTrials.gov · NCT01881074 · Registry updated: 2018-09-17

Condition / research focus: Type II Diabetes; Periodontal Disease
Sponsor: University of Florida
Countries with listed sites: United States
Registry dates and results: Start: 2012-06. Completion: 2015-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Triclosan containing toothpaste (drug) — also listed as: Colgate Total
Non-triclosan containing toothpaste (drug) — also listed as: Colgate

Where the study takes place — 1 listed sites

University of Florida
Gainesville, Florida, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment

ClinicalTrials.gov · NCT01882166 · Registry updated: 2018-09-14

Condition / research focus: Infertility, Female
Sponsor: St. Olavs Hospital
Countries with listed sites: Norway
Registry dates and results: Start: 2013-10. Completion: 2015-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

fostimon (drug) — also listed as: urinary FSH
puregon (drug) — also listed as: recombinant FSH

Where the study takes place — 1 listed sites

IVF Unit, St. Olavs Hospital
Trondheim, Norway
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4WithdrawnINTERVENTIONAL

Desogestrel (DSG) and Corifollitropin(FSH-CTP) Alfa for Ovarian Stimulation in Donors

ClinicalTrials.gov · NCT02757287 · Registry updated: 2018-09-05

Condition / research focus: Infertility
Sponsor: Fundacion Dexeus
Countries with listed sites: Spain
Registry dates and results: Start: 2016-05. Completion: 2018-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

FSH-CTP + DESOGESTREL (drug)

Where the study takes place — 1 listed sites

Hospital Quiron Dexeus
Barcelona, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Comparison of Vaginal and Transdermal Oestrogen Before Frozen Thawed Embryo Transfer

ClinicalTrials.gov · NCT03518528 · Registry updated: 2018-08-31

Condition / research focus: Embryo Transfer; Infertility
Sponsor: University Hospital, Angers
Countries with listed sites: France
Registry dates and results: Start: 2018-08-30. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Estradiol 2 MG (drug) — also listed as: provames 2mg
Estradiol 100 µg (drug) — also listed as: vivelledot 100 µg

Where the study takes place — 1 listed sites

CHU Angers
Angers, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial)

ClinicalTrials.gov · NCT02625519 · Registry updated: 2018-08-28

Condition / research focus: Reproductive Techniques, Assisted
Sponsor: Instituto Bernabeu
Countries with listed sites: Spain
Registry dates and results: Start: 2015-12. Completion: 2019-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Urinary follicle-stimulating hormone (drug) — also listed as: urinary FSH, Fostipur®
Recombinant follicle-stimulating hormone (drug) — also listed as: recombinant FSH, Bemfola®

Where the study takes place — 1 listed sites

Instituto Bernabeu
Alicante, Spain
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Lutropin Alfa in Women at Risk of Poor Response

ClinicalTrials.gov · NCT01112358 · Registry updated: 2018-08-28

Condition / research focus: Ovarian Stimulation
Sponsor: Merck KGaA, Darmstadt, Germany
Countries with listed sites: Spain
Registry dates and results: Start: 2005-12-07. Completion: 2007-01-30 (may be estimated). Results are posted in this registry.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

r-FSH (drug) — also listed as: Follitropin alfa; Gonal-F®
r-hLH (drug) — also listed as: Lutropin alfa; Luveris®
Analogous GnRH antagonist (drug) — also listed as: Cetrotide®
r-hCG (drug)
Progesterone (drug)

Where the study takes place — 1 listed sites

Hospital Universitario de La Fe
Valencia, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableWithdrawnINTERVENTIONAL

Sensorimotor Dysfunction in Achalasia

ClinicalTrials.gov · NCT02434991 · Registry updated: 2018-08-16

Condition / research focus: Achalasia
Sponsor: Mayo Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2018-03. Completion: 2018-08-14 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Barostat (device) — also listed as: Sensorimotor dysfunction

Where the study takes place — 1 listed sites

Mayo Clinic in Rochester
Rochester, Minnesota, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Serum Sample Collection to Determine Analytical Performance Characteristics of the ADVIA Centaur PAPPA and BhCG Assays

ClinicalTrials.gov · NCT03629795 · Registry updated: 2018-08-14

Condition / research focus: Trisomy 21 in Fetus; Trisomy 18 in Fetus; Trisomy 13 in Fetus
Sponsor: Axis Shield Diagnostics Ltd
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2017-11-17. Completion: 2018-01-24 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Newcastle University
Newcastle upon Tyne, UK, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Adding L-Carnitine to Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovary Syndrome

ClinicalTrials.gov · NCT03630341 · Registry updated: 2018-08-14

Condition / research focus: Polycystic Ovary Syndrome
Sponsor: Assiut University
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-02-01. Completion: 2018-05 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Clomiphene Citrate 50mg (drug)
L-carnitine (drug)
Placebo Oral Tablet (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Intrauterine Injection of Human Chorionic Gonadotrophin and Pregnancy Rate in ICSI

ClinicalTrials.gov · NCT03445910 · Registry updated: 2018-08-14

Condition / research focus: Repeated Implantation Failure
Sponsor: Ain Shams University
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-02-20. Completion: 2018-07-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human chorionic gonadotropin (drug) — also listed as: Chorimone, pregnyl

Where the study takes place — 1 listed sites

Ain Shams University
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Urine Pregnancy Test Compared to Transvaginal Ultrasound (CHECK-TOP).

ClinicalTrials.gov · NCT02792556 · Registry updated: 2018-08-09

Condition / research focus: Drug Abortion
Sponsor: Hospices Civils de Lyon
Countries with listed sites: France
Registry dates and results: Start: 2016-09. Completion: 2018-09 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Urine pregnancy test (device)

Where the study takes place — 1 listed sites

Hospices Civils de Lyon - Hôpital de la Croix Rousse
Lyon, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Androgen Responses to hCG and Ovarian Morphology in PCOS

ClinicalTrials.gov · NCT03489668 · Registry updated: 2018-08-09

Condition / research focus: PCOS
Sponsor: Poznan University of Medical Sciences
Countries with listed sites: Poland
Registry dates and results: Start: 2018-01-20. Completion: 2020-03-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

MetFORMIN 500 Mg Oral Tablet (drug)

Where the study takes place — 1 listed sites

Division of Infertility and Reproductive Endocrinology, Department of Gynecology and Obsterics
Poznan, Poland
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4TerminatedINTERVENTIONAL

The Luveris In Vitro Fertilization Trial

ClinicalTrials.gov · NCT00889512 · Registry updated: 2018-08-07

Condition / research focus: Infertility; Hypothalamic Amenorrhea; Hyperprolactinemia
Sponsor: University Reproductive Associates
Countries with listed sites: United States
Registry dates and results: Start: 2009-04. Completion: 2013-11 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Luveris fixed dose (drug)
Luveris increasing dose (drug)

Where the study takes place — 1 listed sites

University Reproductive Associates
Hasbrouck Heights, New Jersey, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1WithdrawnINTERVENTIONAL

Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess

ClinicalTrials.gov · NCT01422096 · Registry updated: 2018-07-19

Condition / research focus: Hyperandrogenemia; Obesity; Polycystic Ovary Syndrome
Sponsor: University of Virginia
Countries with listed sites: United States
Registry dates and results: Start: 2018-06-01. Completion: 2018-07-17 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Leuprolide (drug) — also listed as: Depot Lupron

Where the study takes place — 1 listed sites

University of Virginia Center for Research in Reproduction
Charlottesville, Virginia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 22:07 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableCompletedINTERVENTIONAL

Home Pregnancy Test Evaluation Study

ClinicalTrials.gov · NCT03589534 · Registry updated: 2018-11-09

Condition / research focus: Pregnancy Testing
Sponsor: SPD Development Company Limited
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2018-06-06. Completion: 2018-08-13 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

home pregnancy test (diagnostic_test)

Where the study takes place — 1 listed sites

SPD Development Company Ltd.
Bedford, Bedfordshire, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Clearblue Home Pregnancy Test Consumer Study

ClinicalTrials.gov · NCT01279486 · Registry updated: 2018-11-02

Condition / research focus: Pregnancy
Sponsor: SPD Development Company Limited
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2010-12. Completion: 2011-06 (may be estimated). Results are posted in this registry.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 2 listed sites

Bedford General Hospital
Bedford, Bedfordshire, United Kingdom
Site recruitment: Not reported
Brook clinic
Milton Keynes, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients

ClinicalTrials.gov · NCT02273791 · Registry updated: 2018-10-29

Condition / research focus: Infertility; Polycystic Ovarian Syndrome
Sponsor: Mansoura University
Countries with listed sites: Egypt
Registry dates and results: Start: 2013-12. Completion: 2016-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Estradiol valerate (drug) — also listed as: Cycloprogynova (white tablets)
Sequential Clomiphene citrate and Gonadotropin (drug) — also listed as: Sequential Clomid and Menogon

Where the study takes place — 2 listed sites

Fertility Care Unit (FCU) in Mansoura University Hospital
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Not reported
Private fertility care centers
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS

ClinicalTrials.gov · NCT01815138 · Registry updated: 2018-10-26

Condition / research focus: Ovarian Hyperstimulation Syndrome
Sponsor: UConn Health
Countries with listed sites: United States
Registry dates and results: Start: 2013-03. Completion: 2016-10 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG (drug) — also listed as: Pregnyl, Profasi
hCG (drug) — also listed as: Pregnyl, Profasi

Where the study takes place — 1 listed sites

University of Connecticut Health Center
Farmington, Connecticut, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2TerminatedINTERVENTIONAL

Single Agent JNJ-56022473 in MDS and AML Patients FAILING HYPOMETHYLATING AGENT BASED THERAPY

ClinicalTrials.gov · NCT02992860 · Registry updated: 2018-10-25

Condition / research focus: Myelodysplastic Syndrome (MDS); Acute Myeloid Leukemia (AML)
Sponsor: GWT-TUD GmbH
Countries with listed sites: France · Germany
Registry dates and results: Start: 2016-07. Completion: 2018-10 (may be estimated). No results posted in this registry response.

Products and interventions (9)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

JNJ-56022473 (drug) — also listed as: CSL362
Bone marrow analyses and CBC with differential (procedure)
Flow cytometry analyses (other)
Central biobanking (other)
Histopathology analysis (procedure)
Cytogenetic analysis (genetic)
Serum chemistry (procedure)
Automated CBC (procedure)
Pregnancy Test (procedure)

Where the study takes place — 10 listed sites

CHU Nantes
Nantes, France
Site recruitment: Not reported
Hospital Archet 1
Nice, France
Site recruitment: Not reported
Hospital Saint Louis
Paris, France
Site recruitment: Not reported
CHU Toulouse
Toulouse, France
Site recruitment: Not reported
Klinikum Chemnitz gGmbH, Klinik für innere Medizin III
Chemnitz, Germany
Site recruitment: Not reported
Universitätsklinikum Dresden
Dresden, Germany
Site recruitment: Not reported
Heinrich Heine Universität
Düsseldorf, Germany
Site recruitment: Not reported
Marien Hospital GmbH
Düsseldorf, Germany
Site recruitment: Not reported
Technische Universität München, Klinikum rechts der Isar
Munich, Germany
Site recruitment: Not reported
Universitätsklinikum Ulm
Ulm, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Piloting Use of Multi-Level Pregnancy Tests in Remote Abortion Services

ClinicalTrials.gov · NCT03207880 · Registry updated: 2018-09-27

Condition / research focus: Medical Abortion, Complete or Unspecified, Without Complication
Sponsor: Gynuity Health Projects
Countries with listed sites: United States
Registry dates and results: Start: 2017-11-01. Completion: 2018-08-10 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Multi-level pregnancy test (device)

Where the study takes place — 1 listed sites

Gynuity Health Projects
New York, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Periodontal Treatment Response in Type II Diabetic Patients

ClinicalTrials.gov · NCT01881074 · Registry updated: 2018-09-17

Condition / research focus: Type II Diabetes; Periodontal Disease
Sponsor: University of Florida
Countries with listed sites: United States
Registry dates and results: Start: 2012-06. Completion: 2015-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Triclosan containing toothpaste (drug) — also listed as: Colgate Total
Non-triclosan containing toothpaste (drug) — also listed as: Colgate

Where the study takes place — 1 listed sites

University of Florida
Gainesville, Florida, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment

ClinicalTrials.gov · NCT01882166 · Registry updated: 2018-09-14

Condition / research focus: Infertility, Female
Sponsor: St. Olavs Hospital
Countries with listed sites: Norway
Registry dates and results: Start: 2013-10. Completion: 2015-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

fostimon (drug) — also listed as: urinary FSH
puregon (drug) — also listed as: recombinant FSH

Where the study takes place — 1 listed sites

IVF Unit, St. Olavs Hospital
Trondheim, Norway
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4WithdrawnINTERVENTIONAL

Desogestrel (DSG) and Corifollitropin(FSH-CTP) Alfa for Ovarian Stimulation in Donors

ClinicalTrials.gov · NCT02757287 · Registry updated: 2018-09-05

Condition / research focus: Infertility
Sponsor: Fundacion Dexeus
Countries with listed sites: Spain
Registry dates and results: Start: 2016-05. Completion: 2018-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

FSH-CTP + DESOGESTREL (drug)

Where the study takes place — 1 listed sites

Hospital Quiron Dexeus
Barcelona, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Comparison of Vaginal and Transdermal Oestrogen Before Frozen Thawed Embryo Transfer

ClinicalTrials.gov · NCT03518528 · Registry updated: 2018-08-31

Condition / research focus: Embryo Transfer; Infertility
Sponsor: University Hospital, Angers
Countries with listed sites: France
Registry dates and results: Start: 2018-08-30. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Estradiol 2 MG (drug) — also listed as: provames 2mg
Estradiol 100 µg (drug) — also listed as: vivelledot 100 µg

Where the study takes place — 1 listed sites

CHU Angers
Angers, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial)

ClinicalTrials.gov · NCT02625519 · Registry updated: 2018-08-28

Condition / research focus: Reproductive Techniques, Assisted
Sponsor: Instituto Bernabeu
Countries with listed sites: Spain
Registry dates and results: Start: 2015-12. Completion: 2019-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Urinary follicle-stimulating hormone (drug) — also listed as: urinary FSH, Fostipur®
Recombinant follicle-stimulating hormone (drug) — also listed as: recombinant FSH, Bemfola®

Where the study takes place — 1 listed sites

Instituto Bernabeu
Alicante, Spain
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Lutropin Alfa in Women at Risk of Poor Response

ClinicalTrials.gov · NCT01112358 · Registry updated: 2018-08-28

Condition / research focus: Ovarian Stimulation
Sponsor: Merck KGaA, Darmstadt, Germany
Countries with listed sites: Spain
Registry dates and results: Start: 2005-12-07. Completion: 2007-01-30 (may be estimated). Results are posted in this registry.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

r-FSH (drug) — also listed as: Follitropin alfa; Gonal-F®
r-hLH (drug) — also listed as: Lutropin alfa; Luveris®
Analogous GnRH antagonist (drug) — also listed as: Cetrotide®
r-hCG (drug)
Progesterone (drug)

Where the study takes place — 1 listed sites

Hospital Universitario de La Fe
Valencia, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableWithdrawnINTERVENTIONAL

Sensorimotor Dysfunction in Achalasia

ClinicalTrials.gov · NCT02434991 · Registry updated: 2018-08-16

Condition / research focus: Achalasia
Sponsor: Mayo Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2018-03. Completion: 2018-08-14 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Barostat (device) — also listed as: Sensorimotor dysfunction

Where the study takes place — 1 listed sites

Mayo Clinic in Rochester
Rochester, Minnesota, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Serum Sample Collection to Determine Analytical Performance Characteristics of the ADVIA Centaur PAPPA and BhCG Assays

ClinicalTrials.gov · NCT03629795 · Registry updated: 2018-08-14

Condition / research focus: Trisomy 21 in Fetus; Trisomy 18 in Fetus; Trisomy 13 in Fetus
Sponsor: Axis Shield Diagnostics Ltd
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2017-11-17. Completion: 2018-01-24 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Newcastle University
Newcastle upon Tyne, UK, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Adding L-Carnitine to Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovary Syndrome

ClinicalTrials.gov · NCT03630341 · Registry updated: 2018-08-14

Condition / research focus: Polycystic Ovary Syndrome
Sponsor: Assiut University
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-02-01. Completion: 2018-05 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Clomiphene Citrate 50mg (drug)
L-carnitine (drug)
Placebo Oral Tablet (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Intrauterine Injection of Human Chorionic Gonadotrophin and Pregnancy Rate in ICSI

ClinicalTrials.gov · NCT03445910 · Registry updated: 2018-08-14

Condition / research focus: Repeated Implantation Failure
Sponsor: Ain Shams University
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-02-20. Completion: 2018-07-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human chorionic gonadotropin (drug) — also listed as: Chorimone, pregnyl

Where the study takes place — 1 listed sites

Ain Shams University
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Urine Pregnancy Test Compared to Transvaginal Ultrasound (CHECK-TOP).

ClinicalTrials.gov · NCT02792556 · Registry updated: 2018-08-09

Condition / research focus: Drug Abortion
Sponsor: Hospices Civils de Lyon
Countries with listed sites: France
Registry dates and results: Start: 2016-09. Completion: 2018-09 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Urine pregnancy test (device)

Where the study takes place — 1 listed sites

Hospices Civils de Lyon - Hôpital de la Croix Rousse
Lyon, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Androgen Responses to hCG and Ovarian Morphology in PCOS

ClinicalTrials.gov · NCT03489668 · Registry updated: 2018-08-09

Condition / research focus: PCOS
Sponsor: Poznan University of Medical Sciences
Countries with listed sites: Poland
Registry dates and results: Start: 2018-01-20. Completion: 2020-03-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

MetFORMIN 500 Mg Oral Tablet (drug)

Where the study takes place — 1 listed sites

Division of Infertility and Reproductive Endocrinology, Department of Gynecology and Obsterics
Poznan, Poland
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4TerminatedINTERVENTIONAL

The Luveris In Vitro Fertilization Trial

ClinicalTrials.gov · NCT00889512 · Registry updated: 2018-08-07

Condition / research focus: Infertility; Hypothalamic Amenorrhea; Hyperprolactinemia
Sponsor: University Reproductive Associates
Countries with listed sites: United States
Registry dates and results: Start: 2009-04. Completion: 2013-11 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Luveris fixed dose (drug)
Luveris increasing dose (drug)

Where the study takes place — 1 listed sites

University Reproductive Associates
Hasbrouck Heights, New Jersey, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1WithdrawnINTERVENTIONAL

Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess

ClinicalTrials.gov · NCT01422096 · Registry updated: 2018-07-19

Condition / research focus: Hyperandrogenemia; Obesity; Polycystic Ovary Syndrome
Sponsor: University of Virginia
Countries with listed sites: United States
Registry dates and results: Start: 2018-06-01. Completion: 2018-07-17 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Leuprolide (drug) — also listed as: Depot Lupron

Where the study takes place — 1 listed sites

University of Virginia Center for Research in Reproduction
Charlottesville, Virginia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →